Simple Summary Baseline neutrophil-to-lymphocyte ratio≥ 3 was a robust independent
predictor of overall survival after chemoembolization for intermediate-stage hepatocellular …

Background Neutrophil-to-lymphocyte ratio (NLR) is considered as a prognostic predictor of
hepatocellular carcinoma (HCC). However, its prognostic ability is still controversial. This …

The neutrophil-to-lymphocyte ratio (NLR) has recently been reported to predict the
prognosis of hepatocellular carcinoma (HCC). We explored whether NLR predicted the …

Transarterial chemoembolization (TACE) is the preferred treatment for unresectable,
intermediate-stage hepatocellular carcinoma (HCC). However, survival after TACE can be …

Purpose To examine the effect of dynamic changes in neutrophil-to-lymphocyte ratio (NLR)
on tumor response and overall survival (OS) in patients with hepatocellular carcinoma …

Purpose To evaluate whether neutrophil-to-lymphocyte ratio (NLR) and platelet-to-
lymphocyte ratio (PLR) predict survival and metastasis in patients after transarterial …

Background Prospectively predicting response to intra-arterial therapy for hepatocellular
carcinoma (HCC) is challenging. Neutrophil/lymphocyte ratio (NLR) is a serum biomarker …

Background The purpose of this study is to determine and compare the ability of neutrophil-
to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), aspartate-aminotransferase-to …

Purpose To demonstrate that patients with hepatocellular carcinoma (HCC) and elevated
baseline neutrophil/lymphocyte ratio (NLR) have a significantly greater risk of progressive …

Simple Summary Response to TACE is a surrogate marker of tumor aggressive biology, with
manifold practical implications. In turn, inflammation-based scores are biomarkers of the …